Protecting kidneys during cisplatin chemotherapy
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether giving a medicine called aminophylline can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce kidney side effects for people getting cisplatin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 18 years old.
- You must be a cancer patient scheduled to receive cisplatin chemotherapy.
- You must not have existing kidney problems or low kidney function.
- You must not have certain heart, thyroid, liver, or seizure conditions, and must not have used aminophylline in the past 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a supplement called N-acetylcysteine (a type of antioxidant) can help protect the kidneys during cisplatin chemotherapy. Cisplatin is a common cancer drug but can sometimes harm the kidneys, so this trial aims to see if adding this supplement reduces that risk.
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
This study tests whether a medicine called cilastatin can prevent kidney damage caused by certain strong medications. If you are receiving one of these medications and are at risk for kidney injury, this trial may offer protection.
This trial tests whether injecting aminophylline (a medication that relaxes muscles) into the bladder can help doctors place a stent (small tube) to relieve a blocked ureter caused by a kidney stone. The goal is to improve kidney function when one kidney is blocked and not working.
This trial tests two drugs (cilastatin and thiosulfate) to see which one better protects the kidneys during surgery that uses heated cisplatin chemotherapy directly in the abdomen. It is for women with advanced ovarian cancer whose disease is mostly in the belly.
This trial tests if taking N-acetylcysteine (NAC) can help prevent hearing loss caused by high-dose cisplatin chemotherapy. If you're getting cisplatin and are between 18 and 70, you may be able to join.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.